Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Compounds for IL-8-mediated diseases in development at SmithKline Beecham

May 11, 1998

Ortec's CCS granted humanitarian use device designation

May 11, 1998

Favorable results obtained in SomatoKine burn study

May 7, 1998

Solarase receives additional European approvals

May 5, 1998

Topical BCX-34 not effective in phase II

May 4, 1998

hu1124 shows clinical activity in phase I for psoriasis

April 30, 1998

Milkhaus granted patent for scar treatment agent

April 24, 1998

More retinoids emerge from the Allergan pipeline

April 21, 1998

First launch for topical biologic that helps heal diabetic foot ulcers

April 20, 1998

ADCON-L is approvable, FDA says

April 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...